Home › Cancro dello stomaco › Michigan › Detroit
Studi clinici su Cancro dello stomaco a Detroit, MI
16 studi su Cancro dello stomaco cercano partecipanti presso sedi a Detroit e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
The Vanguard Study: Testing a New Way to Screen for Cancer
In reclutamentoVolontari sani benvenuti
- Henry Ford Hospital, Detroit
- Henry Ford Medical Center - Detroit Northwest, Detroit
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
In reclutamentoVolontari sani benvenuti
- Henry Ford Health Saint John Hospital, Detroit
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
In reclutamentoStudio osservazionaleVolontari sani benvenuti
- Henry Ford Hospital, Detroit
- Henry Ford Health Saint John Hospital, Detroit
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
In reclutamentoFase 3
- Henry Ford Health, Detroit
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
In reclutamentoFase 1
- Barbara Ann Karmanos Cancer Institute, Detroit
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
In reclutamentoFase 1
- Barbara Ann Karmanos Cancer Institute, Detroit
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
In reclutamentoFase 1
- Karmanos Cancer Institiute, Detroit
A Phase 1/1b Study of IAM1363 in HER2 Cancers
In reclutamentoFase 1
- Henry Ford Cancer Institute, Detroit
A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
In reclutamentoFase 1/2
- Brigitte Harris Cancer Pavilion BHCP, Detroit
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
In reclutamentoFase 1/2
- Karmanos Cancer Institute, Detroit
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
In reclutamentoFase 1/2
- Henry Ford Cancer Institute, Detroit
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
In reclutamentoFase 1
- Investigative Site #120, Detroit
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
In reclutamentoFase 1
- Karmanos Cancer Institute, Detroit
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
In reclutamentoFase 1
- Henry Ford Health System, Detroit
Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
In reclutamentoFase 1
- Henry Ford Cancer-Detroit, Detroit
A Beta-only IL-2 ImmunoTherapY Study
In reclutamentoFase 1/2
- Karmanos Cancer Institute, Detroit
Studi su Cancro dello stomaco in altre città
- Houston, TX42 studi
- Boston, MA32 studi
- New York City, NY31 studi
- Nashville, TN28 studi
- Baldwin Park, CA22 studi
- Los Angeles, CA22 studi
- Arlington, VA20 studi
- Dallas, TX19 studi
- San Antonio, TX19 studi
- Grand Rapids, MI18 studi
- St. Louis, MO18 studi
- Washington, DC16 studi
Altri studi a Detroit
- Cancro del polmone non a piccole cellule44 studi
- Cancro al seno33 studi
- Cancro (tutti i tipi)29 studi
- Cancro colorettale26 studi
- Cancro ovarico26 studi
- Cancro metastatico24 studi
- Cancro alla prostata22 studi
- Cancro dell'endometrio21 studi
- Cancro ai polmoni20 studi
- Mieloma multiplo19 studi
- Carcinoma a cellule squamose della testa e del collo15 studi
- Leucemia mieloide acuta14 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.